Detalhe da pesquisa
1.
A lactate-induced response to hypoxia.
Cell
; 161(3): 595-609, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892225
2.
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.
Biochem Biophys Res Commun
; 578: 91-96, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547629
3.
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Emerg Microbes Infect
; 11(1): 2315-2325, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006772
4.
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
Nat Commun
; 12(1): 288, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436577
5.
A novel pyruvate kinase M2 activator compound that suppresses lung cancer cell viability under hypoxia.
Mol Cells
; 38(4): 373-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25813626